Literature DB >> 23261166

Emerging roles of PDGF-D in EMT progression during tumorigenesis.

Qiong Wu1, Xin Hou, Jun Xia, Xiujuan Qian, Lucio Miele, Fazlul H Sarkar, Zhiwei Wang.   

Abstract

Platelet-derived growth factor-D (PDGF-D) signaling pathway has been reported to be involved in regulating various cellular processes, such as cell growth, apoptotic cell death, migration, invasion, angiogenesis and metastasis. Recently, multiple studies have shown that PDGF-D plays a critical role in governing epithelial-to-mesenchymal transition (EMT), although the underlying mechanism of PDGF-D-mediated acquisition of EMT is largely unclear. Therefore, this mini review will discuss recent advances in our understanding of the role of PDGF-D in the acquisition of EMT during tumorigenesis. Furthermore, we will summarize the function of chemical inhibitors and natural compounds that are known to inactivate PDGF-D signaling pathway, which leads to the reversal of EMT. In summary, inactivation of PDGF-D could be a novel strategy for achieving better treatment outcome of patients inflicted with cancers.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23261166      PMCID: PMC3619006          DOI: 10.1016/j.ctrv.2012.11.006

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  111 in total

Review 1.  The PDGF family: four gene products form five dimeric isoforms.

Authors:  Linda Fredriksson; Hong Li; Ulf Eriksson
Journal:  Cytokine Growth Factor Rev       Date:  2004-08       Impact factor: 7.638

2.  Off the beaten pathway: the complex cross talk between Notch and NF-kappaB.

Authors:  Clodia Osipo; Todd E Golde; Barbara A Osborne; Lucio A Miele
Journal:  Lab Invest       Date:  2007-12-03       Impact factor: 5.662

Review 3.  The Hedgehog's tale: developing strategies for targeting cancer.

Authors:  Jessica M Y Ng; Tom Curran
Journal:  Nat Rev Cancer       Date:  2011-05-26       Impact factor: 60.716

Review 4.  Cancer treatment and survivorship statistics, 2012.

Authors:  Rebecca Siegel; Carol DeSantis; Katherine Virgo; Kevin Stein; Angela Mariotto; Tenbroeck Smith; Dexter Cooper; Ted Gansler; Catherine Lerro; Stacey Fedewa; Chunchieh Lin; Corinne Leach; Rachel Spillers Cannady; Hyunsoon Cho; Steve Scoppa; Mark Hachey; Rebecca Kirch; Ahmedin Jemal; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2012-06-14       Impact factor: 508.702

Review 5.  Targeting Notch signaling pathway to overcome drug resistance for cancer therapy.

Authors:  Zhiwei Wang; Yiwei Li; Aamir Ahmad; Asfar S Azmi; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Biochim Biophys Acta       Date:  2010-06-22

6.  Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.

Authors:  Yiwei Li; Timothy G VandenBoom; Dejuan Kong; Zhiwei Wang; Shadan Ali; Philip A Philip; Fazlul H Sarkar
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

7.  Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2.

Authors:  Xiaobo Wang; Karine Belguise; Nathalie Kersual; Kathrin H Kirsch; Nora D Mineva; Florence Galtier; Dany Chalbos; Gail E Sonenshein
Journal:  Nat Cell Biol       Date:  2007-03-18       Impact factor: 28.824

8.  miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells.

Authors:  Dejuan Kong; Yiwei Li; Zhiwei Wang; Sanjeev Banerjee; Aamir Ahmad; Hyeong-Reh Choi Kim; Fazlul H Sarkar
Journal:  Stem Cells       Date:  2009-08       Impact factor: 6.277

9.  Up-regulation of sonic hedgehog contributes to TGF-β1-induced epithelial to mesenchymal transition in NSCLC cells.

Authors:  Ma'in Y Maitah; Shadan Ali; Aamir Ahmad; Shirish Gadgeel; Fazlul H Sarkar
Journal:  PLoS One       Date:  2011-01-13       Impact factor: 3.240

Review 10.  Imatinib: as adjuvant therapy for gastrointestinal stromal tumour.

Authors:  Mark Sanford; Lesley J Scott
Journal:  Drugs       Date:  2010-10-22       Impact factor: 11.431

View more
  34 in total

Review 1.  Role of NRP-1 in VEGF-VEGFR2-Independent Tumorigenesis.

Authors:  Chenxi Hu; Xiaodong Jiang
Journal:  Target Oncol       Date:  2016-08       Impact factor: 4.493

2.  Cytochrome P450 1B1 Contributes to the Development of Angiotensin II-Induced Aortic Aneurysm in Male Apoe(-/-) Mice.

Authors:  Shyamala Thirunavukkarasu; Nayaab S Khan; Chi Young Song; Hafiz U Ghafoor; David D Brand; Frank J Gonzalez; Kafait U Malik
Journal:  Am J Pathol       Date:  2016-06-11       Impact factor: 4.307

3.  Electro-acupuncture treatment improves neurological function associated with downregulation of PDGF and inhibition of astrogliosis in rats with spinal cord transection.

Authors:  Fen Liu; Yu Zou; Sujuan Liu; Jia Liu; Tinghua Wang
Journal:  J Mol Neurosci       Date:  2013-06-08       Impact factor: 3.444

4.  A new era: tumor microenvironment in chemoresistance of pancreatic cancer.

Authors:  Xueping Zhao; Zongze Li; Zongting Gu
Journal:  J Cancer Sci Clin Ther       Date:  2022-02-15

Review 5.  LncRNAs as epigenetic regulators of epithelial to mesenchymal transition in pancreatic cancer.

Authors:  Yan Ma; Yang Di; Qiuyue Li; Qilin Zhan; Xiaomeng He; Shanshan Liu; Heng Zou; Christopher Corpe; Litian Chen; Jin Wang
Journal:  Discov Oncol       Date:  2022-07-11

Review 6.  The wound healing, chronic fibrosis, and cancer progression triad.

Authors:  Brad Rybinski; Janusz Franco-Barraza; Edna Cukierman
Journal:  Physiol Genomics       Date:  2014-02-11       Impact factor: 3.107

7.  Functional malignant cell heterogeneity in pancreatic neuroendocrine tumors revealed by targeting of PDGF-DD.

Authors:  Eliane Cortez; Hanna Gladh; Sebastian Braun; Matteo Bocci; Eugenia Cordero; Niklas K Björkström; Hideki Miyazaki; Iacovos P Michael; Ulf Eriksson; Erika Folestad; Kristian Pietras
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-01       Impact factor: 11.205

8.  Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.

Authors:  Na Zhu; Emilia M Swietlik; Carrie L Welch; Michael W Pauciulo; Nicholas W Morrell; Yufeng Shen; Stefan Gräf; William C Nichols; Wendy K Chung; Jacob J Hagen; Xueya Zhou; Yicheng Guo; Johannes Karten; Divya Pandya; Tobias Tilly; Katie A Lutz; Jennifer M Martin; Carmen M Treacy; Erika B Rosenzweig; Usha Krishnan; Anna W Coleman; Claudia Gonzaga-Jauregui; Allan Lawrie; Richard C Trembath; Martin R Wilkins
Journal:  Genome Med       Date:  2021-05-10       Impact factor: 15.266

9.  Growth factors involve in cellular proliferation, differentiation and migration during prostate cancer metastasis.

Authors:  Ilaha Isali; Mohammed Adel Ali Al-Sadawi; Arshna Qureshi; Ahmad O Khalifa; Mukesh K Agrawal; Sanjeev Shukla
Journal:  Int J Cell Biol Physiol       Date:  2019-10-07

10.  An epigenetic switch regulates the ontogeny of AXL-positive/EGFR-TKi-resistant cells by modulating miR-335 expression.

Authors:  Polona Safaric Tepes; Debjani Pal; Trine Lindsted; Ingrid Ibarra; Amaia Lujambio; Vilma Jimenez Sabinina; Serif Senturk; Madison Miller; Navya Korimerla; Jiahao Huang; Lawrence Glassman; Paul Lee; David Zeltsman; Kevin Hyman; Michael Esposito; Gregory J Hannon; Raffaella Sordella
Journal:  Elife       Date:  2021-07-13       Impact factor: 8.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.